Sorrento Cleared For Ch. 11 Loan Over Nant Entity Objection
Bankrupt pharmaceutical research company Sorrento Therapeutics received interim approval Tuesday for a $75 million Chapter 11 loan after a Texas judge overruled objections from a litigation foe of the debtor's that...To view the full article, register now.
Already a subscriber? Click here to view full article